Dua Asim: Efficacy and Safety of Rivaroxaban Plus Aspirin in PAD Patients
Dua Asim, Third-Year Medical Student at Jinnah Sindh Medical University, shared a post on LinkedIn about a recent article she and her colleagues co-authores, published in Annals of Medicine and Surgery, adding:
“I am pleased to share our recently published systematic review and meta-analysis, ‘Efficacy and Safety of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in Patients with Peripheral Arterial Disease,’ published in Annals of Medicine and Surgery.
This study evaluates dual pathway inhibition using rivaroxaban plus aspirin in patients with peripheral arterial disease.
Our findings suggest that combination therapy may improve cardiovascular and limb-related outcomes; however, it also underscores the importance of careful, individualized risk assessment due to an increased risk of major bleeding.
I am sincerely grateful to my co-authors for their dedication, collaboration, and valuable contributions to this work.”
Title: Efficacy and safety of rivaroxaban plus aspirin compared with aspirin alone in patients with peripheral arterial disease: a systematic review and meta-analysis
Authors: Muhammad Farhan, Syed Hassan Ali, Daniyal Khalid, Adina Kazmi, Dua Asim, Zoha Idrees, Muhammad Saim Siddiqui, Sudais Bin Sohaib, Muhammad Saad Khan, Muhammad Mohsin Khan, Abubakr Mahmoud
Stay updated with Hemostasis Today.
-
Jun 21, 2026, 17:00Jeffrey Schnur: Advanced Treatment Strategies for Deep Vein Thrombosis and Pulmonary Embolism
-
Jun 21, 2026, 16:53Matteo Foschi: When Should We Restart Anticoagulation After a Breakthrough Ischemic Stroke?
-
Jun 21, 2026, 16:21Early Gains in Stroke Knowledge With Stroke Riskometer – International Journal of Stroke
-
Jun 21, 2026, 16:12Cost Savings and Reduced Factor Consumption With Efanesoctocog Alfa – Blood Journals Portfolio
-
Jun 21, 2026, 15:59John Jaksich: Heparin and Anticoagulants – Chemistry, Biotechnology, and Manufacturing
-
Jun 21, 2026, 15:11Mishal Khan: Long-Term Mortality Trends and Demographic Disparities in Patients With PE and AF
-
Jun 21, 2026, 14:57Vimal Koshy Thomas: Adding to the Evidence Base for Endovascular Therapy Beyond 24 Hours
-
Jun 21, 2026, 14:57Abdul Mannan: Integrating Female Reproductive Health into Lifelong Haematology Care
-
Jun 21, 2026, 14:56Ayoub Ait Lahcen: Can We Reduce Blood Transfusions in Cardiac Surgery Before the Operation Even Begins?